Publication
Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.
Alexander Xiao, Saurabh Zanwar, Yi Lin, Prashant Kapoor, Nadine Abdallah, Francis K Buadi, Moritz Binder, Angela Dispenzieri, David Dingli, Morie A Gertz, Wilson Gonsalves, Suzanne R Hayman, Taxiarchis Kourelis, Nelson Leung, Eli Muchtar, Mustaqeem Siddiqui, Melinda Tan, Rahma Warsame, S Vincent Rajkumar, Shaji Kumar
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Extramedullary disease (EMD) is increasingly recognized in relapsed/refractory multiple myeloma (MM), with central nervous system involvement (CNS-MM) representing a rare but highly aggressive manifestation associated with dismal outcomes. Data on its incidence and optimal management, particularly…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMultiple Myelomadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available